| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1315 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1023 | 2021 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 602 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Antibacterials dispensed in the community comprise 85%‐95% of total human antibacterial consumption E Duffy, S Ritchie, S Metcalfe, B Van Bakel, MG Thomas Journal of clinical pharmacy and therapeutics 43 (1), 59-64, 2018 | 99 | 2018 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
| Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ... MedRxiv, 2021.06. 18.21259133, 2021 | 59 | 2021 |
| Impact of a smartphone app on prescriber adherence to antibiotic guidelines in adult patients with community acquired pneumonia or urinary tract infections CH Yoon, SR Ritchie, EJ Duffy, MG Thomas, S McBride, K Read, R Chen, ... PLoS One 14 (1), e0211157, 2019 | 37 | 2019 |
| Association of the HLA-B* 53: 01 allele with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome during treatment of HIV infection with raltegravir M Thomas, C Hopkins, E Duffy, D Lee, P Loulergue, D Ripamonti, ... Clinical Infectious Diseases 64 (9), 1198-1203, 2017 | 34 | 2017 |
| Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... Jama 329 (14), 1183-1196, 2023 | 29 | 2023 |
| The impacts of New Zealand's COVID-19 epidemic response on community antibiotic use and hospitalisation for pneumonia, peritonsillar abscess and rheumatic fever E Duffy, M Thomas, T Hills, S Ritchie The Lancet Regional Health–Western Pacific 12, 2021 | 27 | 2021 |
| Reduced community antibiotic dispensing in New Zealand during 2015–2018: Marked variation in relation to primary health organisation M Thomas, A Tomlin, E Duffy, M Tilyard The New Zealand Medical Journal (Online) 133 (1518), 33-5, 2020 | 13 | 2020 |
| Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis S Briggs, M Broom, E Duffy, R Everts, G Everts, B Lowe, S McBride, ... Journal of Antimicrobial Chemotherapy 76 (8), 2168-2171, 2021 | 12 | 2021 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19—Preliminary report PR Mouncey, F Al-Beidh, KM Rowan, AD Nichol, YM Arabi, D Annane, ... medRxiv, 2021 | 12 | 2021 |
| Survey of antimicrobial stewardship practices in public hospitals in New Zealand district health boards SJ Gardiner, JA Pryer, EJ Duffy The New Zealand Medical Journal (Online) 130 (1458), 27, 2017 | 12 | 2017 |
| A snapshot of antimicrobial use in New Zealand hospitals-a comparison to Australian and English data E Duffy, S Gardiner, T du Plessis, K Bondesio, B Morar The New Zealand Medical Journal (Online) 128 (1421), 82, 2015 | 10 | 2015 |
| Previous antibiotic-related adverse drug reactions do not reduce expectations for antibiotic treatment of upper respiratory tract infections SR Ritchie, KJ Jayanatha, EJ Duffy, J Chancellor, Z Allport, MG Thomas Journal of global antimicrobial resistance 10, 256-260, 2017 | 9 | 2017 |
| Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... JAMA 327 (13), 1247-1259, 2022 | 8 | 2022 |
| Quality of antimicrobial prescribing improved by the introduction of ePrescribing at Auckland City Hospital TR Bowers, EJ Duffy Health Informatics Journal 26 (4), 2375-2382, 2020 | 8 | 2020 |
Ritchie S R; Stephen RitchieUniversity of AucklandVerified email at auckland.ac.nz
